Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic (PDF) Site License Enterprisewide Metabolic Syndrome - Multiple Definitions Complicate Treatment Datamonitor, April 2006, Pages: 293   Description     Table of Contents        Enquire before Buying    Send to a Friend   It is estimated that there are nearly 86 million Metabolic Syndrome patients in the six major markets. Although the patient pool in need of treatment for Metabolic Syndrome is large, the lack of an approved indication for Metabolic Syndrome, the lack of a consensus definition and the aversion of physicians to pharmacotherapy limit the size of the Metabolic Syndrome market, considerably Scope of this title: of this report: - Determination of the prevalence of Metabolic Syndrome and its component conditions - Evaluation of physician awareness of Metabolic Syndrome and its importance, and of physician perceptions of treatment options for the condition - Assessment of the potential of existing drug classes and developmental compounds in the treatment of Metabolic Syndrome - Understanding of the critical issues affecting the Metabolic Syndrome market Report Highlights The lack of a consensus definition for Metabolic Syndrome is complicating the diagnosis and management of patients. Lifestyle intervention may not be the most rational approach when treating Metabolic Syndrome patients. The significant patient potential and unmet need characteristic to the Metabolic Syndrome market are counterbalanced by a significant number of challenges. Reasons to order your copy: - Target physicians more effectively, through an understanding of prescribing behavior and its influences - Assess the impact that the different definitions of the condition have in the management of Metabolic Syndrome - Recognize lucrative target populations, in terms of unmet need and patient potential, in order to successfully position developmental products Customers who bought this item also bought Metabolic Syndrome: New Opportunities in Diagnostics and Therapeutics The Metabolic Syndrome Metabolic Diseases Pipeline Analysis:Focus on Dyslipidemia, Diabetes, and Obesity Barriers to Effective Management of Metabolic Syndrome Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets Stakeholder Insight: Metabolic Syndrome - Ticking Time Bomb Progress in the Treatment and Understanding of Restless Legs Syndrome November 3, 2005 Sjogrens Syndrome: Too many patients to ignore

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster